[This review was originally posted at the Nieman Journalism Lab Flagyl No Rx, on July 8, 2011.]

Google's biggest social effort yet: This is a two-week edition of This Week in Review, so most of our news comes from last week, rather than this week. The biggest of those stories was the launch of Google+, Google's latest and most substantial foray into the social media landscape. TechCrunch had one of the first and best explanations of what Google+ is all about, and Wired's Steven Levy wrote the most comprehensive account of the thinking at Google behind Plus: It's the product of a fundamental philosophical shift from the web as information to the web as people.

Of course, the force to be reckoned with in any big social media venture is Facebook, and even though Google told Search Engine Land it's not made to be a Facebook competitor, Flagyl pics, Google+ was seen by many (including the New York Times) as Google's most ambitious attempt yet to take on Facebook. The design looks a lot like Facebook, and pages for businesses (like Facebook's Fan Pages) are on their way.

Longtime tech blogger Dave Winer was unimpressed at the effort to challenge Facebook, and Om Malik of GigaOM said Facebook has nothing to be afraid of in Google+, though All Facebook's Nick O'Neill said Google+'s ubiquity across the web should present a threat to Facebook, Flagyl No Rx.

But the biggest contrast people drew between Google+ and Facebook was the more intuitive privacy controls built into its Circles feature. Ex-Salon editor Scott Rosenberg wrote a particularly thoughtful post arguing that Google+ more accurately reflects social life than Facebook: "In truth, Facebook started out with an oversimplified conception of social life, Order Flagyl online overnight delivery no prescription, modeled on the artificial hothouse community of a college campus, and it has never succeeded in providing a usable or convenient method for dividing or organizing your life into its different contexts." His thought was echoed by j-prof Jeremy Littau (in two posts) and the Guardian's Dan Gillmor.

Google's other ventures into social media — Buzz, Wave, Orkut — have fallen flat, so it's somewhat surprising to see that the initial reviews for Google+ were generally positive. Among those enamored with it were TechCrunch's MG Siegler, ReadWriteWeb's Marshall Kirkpatrick, Flagyl schedule, social media guru Robert Scoble, and the Huffington Post's Craig Kanalley (though he wondered about Google's timing). It quickly began sending TechCrunch loads of traffic Flagyl No Rx, , and social media marketer Chris Brogan brainstormed 50 ways Google+ could influence the rest of the web.

At the same time, there was some skepticism about its Circles function: TechCrunch's Siegler wondered whether people would use it as intended, and ReadWriteWeb's Sarah Perez said they might not be equipped to handle complicated, changing relationships. Flagyl over the counter, GigaOM's Mathew Ingram, meanwhile, said Circles look great, but they aren't going to be much use until there's a critical mass of people to put in them.

—

Google+ and the news: This being a journalism blog, we're most interested in Google+ for what it means for news. As Poynter's Jeff Sonderman pointed out, the aspect of Google+ that seems to have the most potential is its Sparks feature, Flagyl samples, which allows users to collect recommended news around a specific term or phrase. Former New York Times reporter Jennifer 8, Flagyl No Rx. Lee said Sparks could fill a valuable niche for news organizations in between Facebook and Twitter — sort of a more customizable, less awkward RSS. The University of Missouri’s KOMU-TV has already used it in a live broadcast, and Breaking News’ Cory Bergman gave a few valuable lessons from that organization’s first week on Google+.

CUNY j-prof Jeff Jarvis gave his thoughts on a few potential uses for news: It could be very useful for collaboration and promotion, Flagyl alternatives, but not so much for live coverage. Journalism.co.uk's Sarah Marshall listed several of the same uses, plus interviewing and "as a Facebook for your tweeps." Sonderman suggested a few changes to Google+ to make it even more news-friendly, including allowing news org pages and improving the Sparks search and filtering. Flagyl No Rx, Still, he saw it as a valuable addition to the online news consumption landscape: "It’s a serendipity engine, and if executed well it could make Google+ an addictive source of news discovery."

A bit of Google+-related miscellany before we move on: Social media marketer Christopher Penn gave some tips on measuring Google+, author Neil Strauss condemned the growing culture of Facebook "Likes" (and now Google +1s), and GigaOM's Mathew Ingram offered a rebuttal.

—

Murdoch kills News of the World: In one of the most surprising media-related moves of the year, Rupert Murdoch's News Corp. suddenly shut down one of its most prominent properties, the 168-year-old British tabloid News of the World, buy Flagyl online no prescription, on Thursday. The decision stemmed from a long-running scandal involving NotW investigators who illegally hacked into the phones of celebrities. This week, the Guardian reported that the hacking extended to the voicemail of a murdered 13-year-old girl and possibly the families of dead soldiers, and that the paper's editor, Rebekah Brooks (now the head of News Corp. in Britain) was informed of some of the hacking, Flagyl No Rx. Buy generic Flagyl, Facing an advertising boycott and Parliamentary opposition, Murdoch's son, James, announced News of the World will close this weekend. (The Guardian has the definitive blow-by-blow of Thursday's events.) It was a desperate move, and as the New York Times, paidContent, and many on Twitter noted, order Flagyl from mexican pharmacy, it was almost certainly an attempt to keep the scandal's collateral damage away from Murdoch's proposed BSkyB merger, which was put on hold and possible in jeopardy this week.

Though the closing left hundreds of suddenly out-of-work employees, it may prove less damaging in the big picture for News Corp. than you might expect. Flagyl No Rx, NotW only published on Sundays, and it's widely suspected that its sister tabloid, the Sun, will simply expand to include a Sunday edition to cover for its absence. As one Guardian editor stated, Real brand Flagyl online, the move may simply allow News Corp. to streamline its operation and save cash, and Poynter’s Rick Edmonds called it a smart business move. (Its stock actually went up after the announcement.)

There's plenty that has yet to play out: The Guardian pointed out how evasive James Murdoch's closing letter was, and Brooks, the one that many thought would take the fall for the scandal, is still around. And the investigation is ongoing, with more arrests being made today, fast shipping Flagyl. According to the New Yorker's Ken Auletta and CUNY's Jeff Jarvis, though, the buck stops with Rupert himself and the culture he created.

—

Making journalism easier on Twitter: Twitter has been reaching out to journalists for quite some time now through a media blog, but last week it took things a step further and launched Twitter for Newsrooms, a journalist's guide to using Twitter, with tips on reporting, making conversation, and promoting content, Flagyl No Rx. The Lab's Justin Ellis gave a quick glimpse into the rationale behind the project.

A few people were skeptical: TechCrunch's Alexia Tsotsis suspected that Twitter's preaching to the choir, arguing that for the journalists who come across Twitter for Newsrooms, Flagyl photos, Twitter already is a newsroom. The Journal Register's Steve Buttry called it "more promotional than helpful," and suggested some other Twitter primers for journalists. Ad Age's Matthew Creamer added a tongue-in-cheek guide to releasing your anger on Twitter. Flagyl No Rx, Meanwhile, the Lab's Megan Garber reported on the ideas of NPR and Andy Carvin for improving Twitter's functionality for reporting, including a kind of real-time influence and credibility score for Twitter sources, and a journalism-oriented meme-tracking tool for developing stories.

—

Mobile media and tablet users, profiled: There were several studies released in the past two weeks that are worth noting, starting with Pew's report on e-reader and tablet users. Pew found that e-reader ownership is booming, Flagyl use, having doubled in six months. The Knight Digital Media Center's Amy Gahran reasoned that e-readers are ahead of tablets right now primarily because they're so much cheaper, and offered ideas for news organizations to take advantage of the explosion of e-reader users.

Three other studies related to tablets and mobile media: One study found that a third of tablet users said it's leading them to read print newspapers and magazines less often; another showed that people are reading more on digital media than we think, and mostly in browsers; and a third gave us more evidence that games are still king among mobile apps.

—

Reading roundup: Bunches of good stuff to look through from the past two weeks, Flagyl No Rx. I'll go through it quickly:

— Turns out the "digital first" move announced last month by the Guardian also includes the closing of the international editions of the Guardian and Observer. Flagyl for sale, Jeff Jarvis explained what digital first means, but Suw Charman-Anderson questioned the wisdom the Guardian's strategy. The Lab's Ken Doctor analyzed the economics of the Guardian's situation, as well as the Mail and the BBC's.

— This week in AOL/Huffington Post news: Business Insider revealed some leaked lackluster traffic numbers for Patch sites, and reported that Patch is undergoing a HuffPo-ization. That prompted Judy Sims and Slate's Jack Shafer Flagyl No Rx, to be the latest to rip into Patch's business model, and Shafer followed up to address rebuttals about non-Patch hyperlocal news.

— Google+ was the only interesting Google-related news over the past two weeks: The Lab's Megan Garber wrote about Google's bid to transform mobile ads, potential new directions for Google News, online buy Flagyl without a prescription, and Google highlighting individual authors in search returns. The New York Times' Virginia Heffernan also wrote on Google's ongoing war on "nonsense" content.

— A couple of paywall notes: The Times of London reported that it has 100,000 subscribers a year after its paywall went up, and Dorian Benkoil said the New York Times' plan is working well, the Lab's Megan Garber wrote about the Times adding a "share your access" offer to print subscribers.

— Three practical posts for journalists: Poynter's Jeff Sonderman has tips for successful news aggregation and personalized news delivery, and British j-prof Paul Bradshaw reported on his experience running his blog through a Facebook Page for a month.

— And three bigger-picture pieces to think on: Wetpaint's Ben Elowitz on the shrinking of the non-Facebook web, former Guardian digital editor Emily Bell on the U.S.' place within the global media ecosystem, and the Economist on the role of news organizations in a citizen-driven media world.

Similar posts: Purchase Cipro. Diflucan No Rx. Buy Lipitor No Prescription. Retin A samples. Order Synthroid no prescription. Discount Lipitor.
Trackbacks from: Flagyl No Rx. Flagyl No Rx. Flagyl No Rx. Flagyl coupon. What is Flagyl. Is Flagyl safe.

[This review was originally posted at the Nieman Journalism Lab Bactrim For Sale, on April 1, 2011.]

Putting the Times' pay plan in place: If you read last week's review, the first half of this week's should feel like déjà vu — lots of back-and-forth about the wisdom of The New York Times' new online pay plan, and some more hand-wringing about getting around that plan. If you want to skip that and get to the best stuff, I recommend Staci Kramer, David Cohn, and Megan Garber.

The Times launched its pay system Monday with a letter to its readers (snarkier version courtesy of Danny Sullivan), along with a 99-cent trial offer for the first four weeks and free access for people who subscribe to the Times on Kindle, Bactrim price. Times digital chief Martin Nisenholtz gave a launch-day talk to newspaper execs, highlighted by his assertion that the link economy is not a win-win for content producers and aggregators.

Meanwhile, the discussion about the paywall's worth rolled on. You can find a good cross-section of opinions in this On Point conversation with Ken Doctor, the Journal Register's John Paton, The Times' David Carr, and NYTClean creator David Hayes, Bactrim For Sale. The plan continues to draw support from some corners, Get Bactrim, including The Onion (in its typically ironic style, of course) and PC Magazine's Lance Ulanoff. Former Financial Times reporter Tom Foremski and Advertising Age columnist Simon Dumenco both made similar arguments about the value of the plan, where can i buy cheapest Bactrim online, with Foremski urging us to support the Times as a moral duty to quality journalism and Dumenco ripping the blogosphere's paywall-bashers for not doing original reporting like the Times.

And though the opposition was expressed much more strongly the past two weeks, there was a smattering of dissent about the plan this week, too — some from the Times' mobile users. One theme among the criticism was the cost of developing the plan: Philip Greenspun wondered how the heck the Times spent $40 million on planning and implementation, and former Guardian digital head Emily Bell wrote about the opportunity cost of that kind of investment. Rx free Bactrim, BNET's Erik Sherman proposed that the Times should have invested the money in innovation instead.

A few other interesting thoughts about the Times' pay plan before we get to the wall-jumping debate: Media consultant Judy Sims said the plan might actually make the Times more social Bactrim For Sale, by providing an incentive for subscribers to share articles on social networks to their non-subscribing friends. Spot.Us' David Cohn argued that the plan is much closer to a donation model than a paywall and argued for the Times to offer membership incentives. And Reuters' Felix Salmon talked about how the proposal is changing blogging at the Times.

PaidContent's Staci Kramer said the Times is fighting an uphill battle in the realm of public perception, but that struggle is the Times' own fault, created by its way-too-complicated pay system.

—

The ethics of paywall jumping: With the Times' "pay fence" going into effect, Bactrim pictures, all the talk about ways to get around that fence turned into a practical reality. Business Insider compiled seven of the methods that have been suggested: A browser extension, Twitter feeds, using different computers, NYTClean and a User Script's coding magic, Google (for five articles a day), and browser-switching or cookie-deleting, Bactrim For Sale. Mashable came up with an even simpler one: delete "?gwh=numbers" from the Times page's URL.

Despite such easy workarounds, the Times is still cracking down in other areas: As Search Engine Land's Danny Sullivan noted, it blocks links from all Google sites after the five-articles-per-day limit is reached. Bactrim price, coupon, The Times also quickly (and successfully) requested a shutdown of one of the more brazen free-riding schemes yet concocted — NYT for a Nickel, which charged to access Times articles without paywall restrictions. (It did, however, let up on unauthorized Twitter aggregators of Times content.)

So we all obviously can crawl through the Times' loopholes, but should we. A few folks made efforts to hack through the ethical thicket of the Times' intentional and unintentional loopholes: Times media critic James Poniewozik didn't come down anywhere solid Bactrim For Sale, , but said the Times' leaky strategy "makes the paywall something like a glorified tip jar, on a massive scale—something you choose to contribute to without compulsion because it is the right thing" — except unlike those enterprises, it's for-profit. In a more philosophical take, the Lab's Megan Garber said the ethical conundrum shows the difficulty of trying to graft the physical world's ethical assumptions onto the digital world.

—

A possible +1 for publishers: Google made a big step in the direction of socially driven search this week with the introduction of +1, purchase Bactrim online, a new feature that allows users to vote up certain search results in actions that are visible to their social network. Here are two good explainers of the feature from TechCrunch and Search Engine Land, both of whom note that +1's gold mine is in allowing Google to personalize ads more closely, and that it's starting on search results and eventually moving to sites across the web.

The feature was immediately compared to Facebook's "Like" and Twitter's retweets, Bactrim no rx, though it functions a bit differently from either. As GigaOM's Mathew Ingram noted, because it's Google, it's intrinsically tied to search, which is both an advantage and a disadvantage. As Ingram said, it's smart to add more of a social component to search, but Google's search-centricity makes the "social network" aspect of +1 awkward, just as Buzz and Wave were, Bactrim For Sale. To paraphrase the argument of Frederic Lardinois of NewsGrange: if your +1's go into your Google Profile and no one sees them, do they really make a sound, generic Bactrim.

All this seems to be good news for media sites. Lost Remote's Cory Bergman said that if they essentially become "improve the SEO of this site" buttons, media companies will be pretty motivated to add them to their sites. Likewise, Poynter's Damon Kiesow reasoned that +1 could be a great way for media sites to more deeply involve visitors who arrive via Google, Bactrim duration, who have typically been less engaged than visitors from Facebook and Twitter.

—

Shrinking innovation to spur it: This month's Carnival of Journalism Bactrim For Sale, focuses on how to drive innovation, specifically through the Knight News Challenge and Reynolds Journalism Institute. Most of the posts rolled in yesterday, and they contain a litany of quick, smart ideas of new directions for news innovation and how to encourage it.

A quick sampling: City University London and Birmingham City University j-prof Paul Bradshaw proposed a much broader, smaller-scale News Challenge fund, with a second fund aimed at making those initiatives scale, where can i buy Bactrim online. J-Lab Jan Schaffer said we need to quit looking at innovation so much solely in terms of tools and more in terms of processes and relationships. British journalist Mary Hamilton and Drury j-prof Jonathan Groves both focused on innovation in training, with Groves proposing "innovation change agents" funded by groups like Knight and the RJI to train and transform newsrooms.

Also, University of British Columbia j-prof Alfred Hermida opined on the role of theory in innovation, Lisa Williams of Placeblogger advocated a small-scale approach to innovation, and the University of Colorado's Steve Outing had some suggestions for the RJI fellowship program, Bactrim For Sale.

—

The mechanics of Twitter's information flow: Four researchers from Yahoo and Cornell released a study this week analyzing, as they called it, Buy Bactrim no prescription, "who says what to whom on Twitter." One of their major findings was that half the information consumed on Twitter comes from a group of 20,000 "elite" users — media companies, celebrities, organizations and bloggers. As Mathew Ingram of GigaOM observed, that indicates that the power law that governs the blogosphere is also in effect on Twitter, and big brands are still important even on a user-directed platform, Bactrim no prescription.

The Lab's Megan Garber noted a few other interesting implications of the study, delving into Twitter's two-step flow from media to a layer of influential sources to the masses, as well as the social media longevity of multimedia and list-oriented articles. A couple of other research-oriented items about Twitter: A Lab post on Dan Zarrella's data regarding timing and Twitter posts, and Maryland prof Zeynep Tufekci wrote a more theoretical post on NPR's Andy Carvin and the process of news production on Twitter.

—

Reading roundup: Plenty of other bits and pieces around the future-of-news world this week:

— New York Times editor Bill Keller wrote a second column Bactrim For Sale, , and like his anti-aggregation piece a couple of weeks ago, this piece — about the value of the Times' impartiality and fact-based reporting — didn't go over well. Buy Bactrim without prescription, Reuters' Felix Salmon called him intellectually dishonest, Scott Rosenberg called him defensive, and the Huffington Post's Peter Goodman (a former Times reporter) said Keller misrepresented him.

— A few notes on The Daily: Forbes' Jeff Bercovici said it was downloaded 500,000 times during its trial period and has 70,000 regular users, and a study was conducted finding that it's more popular with less tech-savvy, purchase Bactrim for sale, less content-concerned users.

— Journal Register Co. CEO John Paton talked about transforming newspapers at the Newspaper Association of America convention; he summarized what he had to say in 10 tweets, and Alan Mutter wrote a post about the panel. The moderator, Ken Doctor, wrote a Lab post looking at how long newspapers have left.

— I'll send you off with Jonathan Stray's thoughtful post on rethinking journalism as a system for informing people, rather than just a series of stories. It's a lot to chew on, but a key piece to add to the future-of-news puzzle.

Similar posts: Buy Tramadol No Prescription. Order Flagyl. Tramadol Over The Counter. Purchase Armour. Cheap Retin A no rx. Purchase Glucophage for sale.
Trackbacks from: Bactrim For Sale. Bactrim For Sale. Bactrim For Sale. Bactrim dosage. Ordering Bactrim online. Buy cheap Bactrim no rx.

[This review was originally posted at the Nieman Journalism Lab Bactrim Cost, on Feb. 4, 2011.]

Al Jazeera, the network, and social activism: For the last week, the eyes of the world have been riveted to the ongoing protests in Egypt, and not surprisingly, the news media themselves have been a big part of that story, Bactrim interactions, too. Many of them have been attacked by President Hosni Mubarak's lackeys, but the crisis has also been a breeding ground for innovative journalism techniques. Mashable put together a roundup of the ways journalists have used Twitter, Facebook, streaming video, Bactrim without a prescription, Tumblr, and Audioboo, and the Lab highlighted reporting efforts on Facebook, curation by Sulia, and explainers by Mother Jones. Google and Twitter also created Speak to Tweet to allow Egyptians cut off from the Internet to communicate.

But the organization that has shined the brightest over the past 10 days is unquestionably Al Jazeera, Bactrim Cost. The Qatar-based TV network has dominated web viewing, and has used web audio updates and Creative Commons to get information out quickly to as many people as possible, Bactrim long term.

Al Jazeera also faced stiff censorship efforts from the Egyptian government, which stripped its Egyptian license and shut down its Cairo bureau, then later stole some of its camera equipment. Through it all, the broadcaster kept up live coverage that online and offline, was considered the most comprehensive of any news organization. Low dose Bactrim, As Lost Remote's Cory Bergman pointed, Al Jazeera's coverage showed the continued power of compelling live video in a multimedia world.

Salon's Alex Pareene called Al Jazeera's coverage Bactrim Cost, an indictment on the U.S.' cable networks, and CUNY j-prof Jeff Jarvis and others urged cable companies to carry Al Jazeera English. Tech pioneer Doc Searls used the moment as a call for a more open form of cable TV: "The message cable should be getting is not just 'carry Al Jazeera,' but 'normalize to the Internet.' Open the pipes. Give us à la carte choices. Let us get and pay for what we want, not just what gets force-fed in bundles."

The protests also served as fresh fuel for an ongoing debate about the role of social media in social change and global political activism. Several critics — including Wired's David Kravets, Bactrim no rx, The New Yorker's Malcolm Gladwell, and SUNY Oswego prof Ulises Mejias— downplayed the role of social media tools such as Twitter in protests like Egypt's. Others, though, countered with a relatively unified theme: It's not really about the media tools per se, but about the decentralized, hyperconnected network in which they are bound up. J-profs Jeremy Littau and Robert Hernandez, along with GigaOM's Mathew Ingram, wrote the most thoughtful versions of this theme, and they're all worth checking out, Bactrim Cost.

—

Tepid reviews for The Daily: Within the bubble of media geeks, one story dominated the others this week: On Wednesday, Rupert Murdoch's News Corp. released The Daily, the first daily updated news publication produced specifically for the iPad. Bactrim photos, If you can't get enough coverage of The Daily, go check out Mediagazer's smorgasbord of links. I'll try to offer you a digestible (but still a bit overwhelming, I'll admit) summary of what people are saying about it.

Leading up to Wednesday's launch, Poynter's Damon Kiesow found many of the people who are working for the heretofore secretive publication, and media analyst Alan Mutter and All Things Digital's Peter Kafka examined the reasons why it might or might not take off. Bactrim Cost, Once the app was released Wednesday afternoon, the reviews came pouring in.

First, buy Bactrim online cod, the good: The first impressions of most of the digital experts polled by Poynter were positive, with several praising its visual design and one calling it "what I’ve always hoped newspapers would do with their tablet editions." PaidContent's Staci Cramer was generally complimentary, and The Guardian's Ian Betteridge gave it a (not terribly enthusiastic) "buy."

Most of the initial reviews, though, were not so kind. Much of the 'meh' was directed at lackluster content, Where can i find Bactrim online, as reviewer after reviewer expressed similar sentiments: "a general-interest publication that is not generally interesting" (The Columbia Journalism Review); "Murdoch’s reinvention of journalism looks a lot like the one before it" (Macworld); "fairly humdrum day-old stories that you might read in, well…a regular old printed newspaper" (Mathew Ingram); "little [of Murdoch's money], it appears, has been invested in editorial talent" (Mashable); "the Etch A Sketch edition of Us Magazine" (Alan Mutter); "barely brings digital journalism into the late 20th century, much less the 21st" (Mark Potts).

The bulk of that criticism seemed to be built on two foundational questions, asked by the Lab's Joshua Benton, which The Daily has apparently yet to answer convincingly: "Who is The Daily trying to reach, order Bactrim from mexican pharmacy. What problem is it trying to solve?" TechCrunch (and several of the above reviewers) asked similar questions, and GigaOM's Darrell Etherington attempted an answer, arguing that it's not for the obsessively-Twitter-checking news junkies, but iPad users struggling to adjust to life after newspapers.

A few other issues surrounding The Daily that drew attention: One was its separation from the web by virtue of its place within the proprietary iTunes Store and iPad, as well as the complete lack of links in or out, Bactrim Cost. (That hasn't stopped an authorized daily index of links to the web versions of articles from springing up, though.) Salon alum Scott Rosenberg and j-prof Dan Kennedy led the charge against the walled garden, Bactrim dosage, while the Lab's Megan Garber pointed out the draconian anti-aggregation language on The Daily's AP content, and Justin Ellis wondered how user engagement will work in that closed environment.

Then there were the economics of the publication: Media analyst Ken Doctor had two good sets of questions about what it will take for The Daily to financially succeed (the latter is more number-crunchy). Jeff Jarvis also looked at some possible numbers, and media consultant Amy Gahran chastised Murdoch for investing so much money in the venture. Gahran also looked at the hazards of dealing with Apple, and paidContent's Staci Kramer noted that Murdoch wants Apple to lower its share of the subscription revenue. Bactrim Cost, And on the News Corp. front, Bactrim alternatives, Slate's Jack Shafer wrote about the role Murdoch's impatience will play in its fate, and Subhub's Evan Radowski gave us a history lesson on News Corp. initiatives like this one.

—

Apple strikes against e-publishers: In its ongoing tightening of App Store access and regulations, Apple made a significant move this week by rejecting a Sony iPhone app that would have allowed users to buy e-books from the Sony Reader Store. GigaOM's Mathew Ingram did a great job of putting the decision in the context of Apple's past moves, No prescription Bactrim online, explaining why they make good business sense: "What’s the point of controlling a platform like the iPhone and the iPad if you can’t force people to pay you a carrying charge for hosting their content and connecting them with their customers?"

But others (even at GigaOM) were more skeptical. Jason Kincaid of TechCrunch said the decision underscores the downside of closed content platforms, and posited that it's the first shot in a war between Apple and Amazon's Kindle, and Slate's Farhad Manjoo urged Amazon to pull its Kindle app out of the App Store. In another widely expected move along the same lines, Apple also told publishers that within two months, any app that doesn't take payments through its iTunes Store would be rejected, Bactrim Cost.

—

AOL follows Demand's content-farming path: We talked last week about Demand Media's explosive IPO and Google's intention to make content farms harder to find in searches, and we have a couple of updates to those issues this week. First, Seamus McCauley of Virtual Economics explained why he's skeptical about Demand's true valuation, not to mention its accounting methods, doses Bactrim work. And while Google's algorithm limiting content farms is not yet live, search engine startup Blekko has banned many content farm domains, including Demand's eHow, from its search results. Meanwhile, the debate over Demand continued, Buy no prescription Bactrim online, with Adotas' Gavin Dunaway and MinnPost's John Reinan delivering this week's broadsides against the company. Bactrim Cost, AOL hasn't been talked about as a content farm too much as of yet, but that may change after Business Insider's publication this week of a leaked internal document called "The AOL Way," which reads a lot like the textbook content farm strategy guide. GigaOM's Mathew Ingram and Fortune's Dan Mitchell blasted the plan, with Ingram asserting that "the chasing of eyeballs and pageviews is a game of constantly diminishing returns." Martin Bryant of The Next Web, on the other hand, said AOL's model is not a misguided, diabolical plan, but "an inevitable, turbo-powered evolution of what’s happened in the media industry for many years."

—

Reading roundup: A few things to check out this weekend while you're most likely snowed in somewhere:

— This week's WikiLeaks update: Julian Assange sat down with 60 Minutes for an interview (there's also a video on what it took to make that happen), buy cheap Bactrim, WikiLeaks was nominated for the Nobel Peace Prize, The Guardian's Alan Rusbridger gave his own account about working with WikiLeaks, and NYU's Adam Penenberg made the case for Assange as a journalist. Reuters also profiled the new WikiLeaks spinoff OpenLeaks.

— A few paid-content notes: The New York Times isn't releasing details of its paywall plan just yet, but it is fixing technological glitches with the system right now, while Media Week reported that some industry analysts are skeptical of its chances. Meanwhile, the Philadelphia Inquirer and Daily News announced they'll start offering an e-edition to paying subscribers.

— GigaOM founder Om Malik wrote a simple but insightful guide to creating a successful consumer Internet service, focusing on three elements: A clear purpose, ease of use, and fun.

— Harvard prof David Weinberger has a short, thought-provoking post offering a 21st-century update on Marshall McLuhan's famous "The medium is the message" aphorism: "We are the medium." It's a simple idea, but it has some potentially profound implications, a few of which Weinberger begins to flesh out.

Similar posts: Bactrim Dosage. Zoloft Cost. Bactrim Price. Cipro no prescription. Taking Retin A. Order Flagyl from mexican pharmacy.
Trackbacks from: Bactrim Cost. Bactrim Cost. Bactrim Cost. Purchase Bactrim online no prescription. Bactrim australia, uk, us, usa. Where can i find Bactrim online.

[This review was originally posted at the Nieman Journalism Lab Tramadol Over The Counter, on Jan. 7, 2011.]

A net neutrality compromise: The Review might have taken two weeks off for the holidays, but the rest of the future-of-news world kept on humming. Consider this more your "Holidays in Review" than your "Week in Review." Let's get to it.

The biggest news development of the past few weeks came just before Christmas, when the FCC passed a set of Internet regulations that were widely characterized as a compromise between net neutrality advocates and big Internet service providers. Tramadol pharmacy, In essence, the rules will keep ISPs from blocking or slowing services on the traditional wired Internet, but leave the future of wireless regulation more unclear. (Here's a copy of the order and a helpful explainer from GigaOM.)

In the political realm, the order drew predictable responses from both sides of the aisle: Conservatives (including at least one Republican FCC commissioner) were skeptical of a move toward net neutrality, while liberals (like Democratic Sen. Al Franken) fervently argued for it, Tramadol Over The Counter. In the media-tech world, it was greeted — as compromises usually are — with near-universal disdain. The Economist ran down the list of concerns for net neutrality proponents, led by the worry that the FCC "has handed the wireless carriers a free pass." This was especially troubling to j-prof Dan Kennedy, who argued that wireless networks will be far more important to the Internet's future than wired ones, Tramadol samples.

Salon's Dan Gillmor said the FCC paid lip service to net neutrality, paving the way for a future more like cable TV than the open web we have now. Newsweek's Dan Lyons compressed his problems with the order into one statement: "There will soon be a fast Internet for the rich and a slow Internet for the poor."

From the other side, Slate media critic Jack Shafer, a libertarian, questioned whether the FCC had the power to regulate the Internet at all, Order Tramadol no prescription, and imagined what the early Internet would have been like if the FCC had regulated it then. The Los Angeles Times' James Rainey told both sides Tramadol Over The Counter, to calm down, and at the Knight Digital Media Center, Amy Gahran used the story as an object lesson for news organizations in getting and linking to the source documents in question.

—

WikiLeaks and the media's awkward dance: The long tail of this fall's WikiLeaks story continues to run on, meandering into several different areas over the holidays. There are, of course, ongoing efforts to silence WikiLeaks, both corporate (Apple pulled the WikiLeaks app from its store) and governmental (a bill to punish circulation of similar classified information was introduced, and criticized by law prof Geoffrey Stone), online buying Tramadol.

In addition, Vanity Fair published a long piece examining the relationship between WikiLeaks' Julian Assange and The Guardian, the first newspaper to partner with him. Based on the story, Slate's Jack Shafer marveled at Assange's shrewdness and gamesmanship ("unequaled in the history of journalism"), Reuters' Felix Salmon questioned Assange's mental health, Buy cheap Tramadol, and The Atlantic's Nicholas Jackson wondered why The Guardian still seems to be playing by Assange's rules.

We also saw the blowup of Salon columnist Glenn Greenwald's feud with Wired over some chat logs between alleged WikiLeaks leaker Bradley Manning and the man who turned him in, Tramadol Over The Counter. It's a complicated fight I'm not going to delve into here, but if you'd like to know more, here are two good blow-by-blows, one more partial to Wired, and another more sympathetic to Greenwald.

Greenwald has also continued to be one of the people leading the inquiries into the traditional media's lack of support for WikiLeaks. Alternet rebutted several media misconceptions about WikiLeaks, rx free Tramadol, and Newsweek attempted to explain why the American press is so lukewarm on WikiLeaks — they aren't into advocacy, and they don't like Assange's purpose or methods. One of the central questions to that media cold-shoulder might be whether Assange is considered a journalist, something GigaOM's Mathew Ingram tried to tackle. Tramadol Over The Counter, Other, more open critiques of WikiLeaks continue to trickle out, including ones from author Jaron Lanier and Floyd Abrams, a lawyer who argued for The New York Times in the Pentagon Papers case. Abrams' argument prompted rebuttals from Jack Shafer and NYU prof Clay Shirky. Shirky in particular offered a nuanced comparison of the Pentagon Papers-era Times and the globally oriented WikiLeaks, concluding that "the old rules will not produce the old outcomes." If you're still hungry for WikiLeaks analysis, Tramadol trusted pharmacy reviews, John Bracken's rounded up the best of the year here.

—

Looking back, and looking forward: We rang in the new year last week, and that, of course, always means two things in the media world: year-end retrospectives, and previews of the year to come. The Lab wrapped up its own year in review/preview before Christmas with a review of Martin Langeveld's predictions for 2010. PBS' MediaShift also put together a good set of year-end reviews, order Tramadol online c.o.d, including ones on self-publishing, the rapidly shifting magazine industry, a top-ten list of media stories (led by WikiLeaks, Facebook, and the iPad). You can also get a pretty good snapshot of the media year that was by taking a look at AOL's list of the top tech writing of 2010.

Poynter's Rick Edmonds examined the year in newspaper stock prices (not great, but could've been worse), while media consultant Alan Mutter explained that investors tended to stay away from debt-laden newspaper companies in particular, Tramadol Over The Counter. Get Tramadol, As for the year to come, the Lab's readers weighed in — you like ProPublica, The Huffington Post, and Clay Shirky, and you're split on paywalls — and several others chimed in with their predictions, too. Among the more interesting prognostications: New York Times media critic David Carr sees tablets accelerating our ongoing media convergence, The Next Web forecasts a lot of blogs making the Gawker-esque beyond the blog format, online buy Tramadol without a prescription, Mashable's Vadim Lavrusik predicts the death of the foreign correspondent, TBD's Steve Buttry sees many journalism trade organizations merging, and the Lab's Martin Langeveld thinks we'll see John Paton's innovative measures at the Journal Register Co. slowly begin to be emulated elsewhere in the newspaper industry.

Two other folks went outside the predictions mold for their 2011 previews: media analyst Ken Doctor looked at 11 pieces of conventional wisdom the media industry will test this year, and the University of Colorado's Steve Outing outlined his wishes for the new year. Tramadol Over The Counter, Specifically, he wants to see News Corp. My Tramadol experience, and The New York Times' paid-content plans fail, and to see news execs try a value-added membership model instead. "This will require that news publishers actually work their butts off to sell, rather than sit back and expect people to fork over money "just because" everyone should support journalism," he wrote.

—

Rethinking publishing for the tablet: One theme for the new year in media that's already emerged is the impending dominance of the tablet. As The New York Times' Joshua Brustein wrote, that was supposed to be the theme last year, too, Tramadol recreational, but only the iPad was the only device able to get off the ground in any meaningful way. Several of Apple's competitors are gearing up to make their push this year instead; The Times' Nick Bilton predicted that companies that try to one-up Apple with bells and whistles will fail, though Google may come up with a legitimate iPad rival.

Google has begun work toward that end, looking for support from publishers to develop a newsstand to compete with Apple's app store, Tramadol Over The Counter. And Amazon's Kindle is doing fine despite the iPad's popularity, TechCrunch argued. Meanwhile, Tramadol from mexico, Women's Wear Daily reported that magazine app sales on the iPad are down from earlier in the year, though Mashable's Lauren Indvik argued that the numbers aren't as bad as they seem.

The magazine numbers prompted quite a bit of analysis of what's gone wrong with magazine apps. British entrepreneur Andrew Walkingshaw ripped news organizations for a lack of innovation in their tablet editions — "tablets are always-on, tactile, completely reconfigurable, great-looking, permanently jacked into the Internet plumbing, Tramadol results, and you’re using them to make skeumorphic newspaper clones?" — and French media consultant Frederic Filloux made similar points, urging publishers to come up with new design concepts and develop a coherent pricing structure (something Econsultancy's Patricio Robles had a problem with, too). Tramadol Over The Counter, There were plenty of other suggestions for tablet publications, too: GigaOM's Mathew Ingram said they should focus on filtering the web, MG Siegler of TechCrunch asked for an easy-to-use newsstand rather than a system of standalone apps, and Alan Mutter suggested magazines lower the prices and cut down on the technical glitches.

Three others focused specifically on the tablet publishing business model: At the Lab, Ken Doctor gave us three big numbers to watch in determining where this is headed, entrepreneur Bradford Cross proposed a more ad-based model revolving around connections to the open web, After Tramadol, and venture capitalist Fred Wilson predicted that the mobile economy will soon begin looking more like the web economy.

—

Reading roundup: A few items worth taking a look at over the weekend:

— The flare-up du jour in the tech world is over RSS, and specifically, whether or not it is indeed still alive. Web designer Kroc Camen suggested it might be dying, TechCrunch's MG Siegler fingered Twitter and Facebook as the cause, Dave Winer (who helped develop RSS) took umbrage, and GigaOM's Mathew Ingram and The Guardian's Martin Belam defended RSS' relevance.

— Add the Dallas Morning News to the list of paywalled (or soon-to-be-paywalled) papers to watch: It announced it will launch a paid-content plan Feb. 15, Tramadol Over The Counter. The Lab's Justin Ellis shed light on Morning News' thinking behind the plan. PaidContent's Staci Kramer alsobroke down a Pew report on paying for online content.

— For the many writers are considering how to balance social media and longer-form writing, two thoughtful pieces to take a look at: Wired's Clive Thompson on the way tweets and texts can work in concert in-depth analysis, and Anil Dash on the importance of blogging good ideas.

— Finally, NPR's Matt Thompson put together 10 fantastic lessons for the future of media, all coming from women who putting them into action. It's an encouraging, inspiring set of insights.

Similar posts: Purchase Cephalexin. Order Glucophage. Lipitor Price. Low dose Zoloft. Lipitor duration. Zoloft pictures.
Trackbacks from: Tramadol Over The Counter. Tramadol Over The Counter. Tramadol Over The Counter. Tramadol natural. Tramadol pharmacy. Tramadol no rx.

[This review was originally posted at the Nieman Journalism Lab Purchase Zoloft, on Dec. 10, 2010.]

Only one topic really grabbed everyone's attention this week in future-of-news circles (and most of the rest of the world, too): WikiLeaks. To make the story a bit easier to digest, I've divided it into two sections — the crackdown on WikiLeaks, and its implications for journalism. Buy no prescription Zoloft online, Attacks and counterattacks around WikiLeaks: Since it released 250,000 confidential diplomatic cables last week, WikiLeaks and its founder, Julian Assange, have been at the center of attacks by governments, international organizations, and private businesses. The forms and intensity they've taken have seemed unprecedented, buy Zoloft online no prescription, though Daniel Ellsberg said he faced all the same things when he leaked the Pentagon Papers nearly 40 years ago.

Here's a rundown of what's happened since late last week: Both Amazon and the domain registry EveryDNS.net booted WikiLeaks, leaving it scrambling to stay online, Purchase Zoloft. (Here's a good conversation between Ethan Zuckerman and The Columbia Journalism Review on the implications of Amazon's decision.) PayPal, the company that WikiLeaks uses to collect most of its donations, cut off service to WikiLeaks, too. PayPal later relented, Low dose Zoloft, but not before botching its explanation of whether U.S. government pressure was involved.

On the government side, the Library of Congress blocked WikiLeaks, and Assange surrendered to British authorities on a Swedish sexual assault warrant (the evidence for which David Cay Johnston said the media should be questioning) and is being held without bail. Slate's Jack Shafer said the arrest could be a blessing in disguise Purchase Zoloft, for Assange.

WikiLeaks obviously has plenty of critics: Christopher Hitchens called Assange a megalomaniac who's "made everyone complicit in his own private decision to try to sabotage U.S. foreign policy," and U.S, discount Zoloft. Sens. Dianne Feinstein and Joe Lieberman called for Assange and The New York Times, respectively, to be prosecuted via the Espionage Act. But WikiLeaks' many online defenders also manifested themselves this week, too, as hundreds of mirror sites cropped up when WikiLeaks' main site was taken down, Zoloft maximum dosage, and various online groups attacked the sites of companies that had pulled back on services to WikiLeaks. By Wednesday, it was starting to resemble what Dave Winer called "a full-out war on the Internet."

Search Engine Land's Danny Sullivan looked at the response by WikiLeaks' defenders to argue that WikiLeaks will never be blocked, and web pioneer Mark Pesce said that WikiLeaks has formed the blueprint for every group like it to follow, Purchase Zoloft. Many other writers and thinkers lambasted the backlash against WikiLeaks, including Reporters Without Borders, Business Insider's Henry Blodget, Roberto Arguedas at Gizmodo, BoingBoing's Xeni Jardin, Wired's Evan Hansen, where can i buy Zoloft online, and David Samuels of The Atlantic.

Four defenses of WikiLeaks' rights raised particularly salient points: First, NYU prof Clay Shirky argued that while WikiLeaks may prove to be damaging in the long run, democracy needs it to be protected in the short run: "If it’s OK for a democracy to just decide to run someone off the internet for doing something they wouldn’t prosecute a newspaper for doing, the idea of an internet that further democratizes the public sphere will have taken a mortal blow." Second, CUNY j-prof Jeff Jarvis said that WikiLeaks fosters a critical power shift from secrecy to transparency. Zoloft blogs, Finally, GigaOM's Mathew Ingram and Salon's Dan Gillmor made similar points about the parallel between WikiLeaks' rights and the press's First Amendment rights. Whether we agree with them or not, Assange and WikiLeaks are protected under the same legal umbrella as The New York Times, they argued, and every attack on the rights of the former is an attack on the latter's rights, too. Purchase Zoloft, "If journalism can routinely be shut down the way the government wants to do this time, we'll have thrown out free speech in this lawless frenzy," Gillmor wrote.

—

WikiLeaks and journalism: In between all the attacks and counterattacks surrounding him, buy Zoloft from mexico, Julian Assange did a little bit of talking of his own this week, too. He warned about releasing more documents if he's prosecuted or killed, including possible Guantánamo Bay files. He defended WikiLeaks in an op-ed in The Australian. He answered readers' questions at The Guardian, Zoloft canada, mexico, india, and dodged one about diplomacy that started an intriguing discussion at Jay Rosen's Posterous. When faced with the (rather pointless) question of whether he's a journalist, he responded with a rather pointless answer, Purchase Zoloft.

Fortunately, plenty of other people did some deep thinking about what WikiLeaks means for journalism and society. (The Atlantic's Alexis Madrigal has a far more comprehensive list of those people's thoughts here.) Former Guardian web editor Emily Bell argued that WikiLeaks has awakened journalism to a renewed focus on the purpose behind what it does, as opposed to its current obsession with the models by which it achieves that purpose. Here at the Lab, USC grad student Nikki Usher listed a few ways that WikiLeaks shows that both traditional and nontraditional journalism matter and pointed out the value of the two working together.

At the Online Journalism Review, Zoloft from canadian pharmacy, Robert Niles said that WikiLeaks divides journalists into two camps: "Those who want to see information get to the public, by whatever means, and those who want to control the means by which information flows." Honolulu Civil Beat editor John Temple thought a bit about what WikiLeaks means for small, local news organizations like his, and British j-prof Paul Bradshaw used WikiLeaks as a study in how to handle big data dumps journalistically. Purchase Zoloft, Also at the Lab, CUNY j-prof C.W. Anderson had some thoughts about this new quasi-source in the form of large databases, Buying Zoloft online over the counter, and how journalists might be challenged to think about it. Finally, if you're looking for some deep thoughts on WikiLeaks in audio form, Jay Rosen has you covered — in short form at PBS MediaShift, and at quite a bit more length with Dave Winer on their Rebooting the News podcast.

—

How porous should paywalls be?: Meanwhile, the paid-content train chugs along, led by The New York Times, australia, uk, us, usa, which is still planning on instituting its paywall next year. The Times' digital chief, Martin Nisenholtz, dropped a few more details this week about how its model will work, again stressing that the site will remain open to inbound links across the web.

But for the first time, Nisenholtz also stressed the need to limit the abuse of those links as a way to get inside the wall without paying, revealing that The Times will be working with Google to limit the number of times a reader can access Times articles for free via its search, Purchase Zoloft. Nisenholtz also hinted at the size of the paywall's target audience, Buy Zoloft from canada, leading Poynter's Rick Edmonds to estimate that The Times will be focusing on about 6 million "heavy users of the site."

Reuters' Felix Salmon was skeptical of Nisenholtz's stricter paywall plans, saying that they won't be worth the cost: "Strengthening your paywall sends the message that you don’t trust your subscribers, or your subscribers’ non-subscriber friends: you’re treating them as potential content thieves." The only way such a strategy would make sense, he said, is if The Times is considering starting at a very high price point, something like $20 a month. Henry Blodget of Business Insider, on the other hand, Zoloft schedule, is warming to the idea of a paywall for The Times.

In other paid-content news: News Corp.'s Times of London, which is running a very different paywall from The New York Times, may have only 54,000 people accessing content behind it, according to research by the competing Guardian. Zoloft dosage, The Augusta (Ga.) Chronicle announced it's launching an metered model powered by Steve Brill's Press+, a plan Steve Yelvington defended and Matthew Terenzio questioned. Purchase Zoloft, While one paid-content plan gets started, another one might be coming to an end: Newsday is taking its notoriously unsuccessful paywall down through next month, and several on Twitter guessed that the move would become permanent. One news organization that's not going to be a pioneer in paid online news: The Washington Post, as Post Co. CEO Don Graham said at a conference this week.

—

Reading roundup: Other than the ongoing WikiLeaks brouhaha, it's been a relatively quiet week on the future-of-news front. Here's a bit of what else went on:

— Web guru Tim O'Reilly held his News Foo Camp in Arizona last weekend, and since it was an intentionally quiet event, it didn't dominate the online discussion like many such summits do. Still, there were a few interesting post-Newsfoo pieces for the rest of us to chew on, including a roundup of the event by TBD's Steve Buttry, Alex Hillman's reflections, and USC j-prof Robert Hernandez's thoughts on journalists' calling a lie a lie, Purchase Zoloft.

— A few iPad bits: News media marketer Earl Wilkinson wrote about a possible image problem with the iPad, All Things Digital's Peter Kafka reported on the negotiations between Apple and publishers on iTunes subscriptions, and The New York Times' David Nolen gave some lessons from designing election results for the iPad.

— The Guardian's Sarah Hartley interviewed former TBD general manager Jim Brady about the ambitious local online-TV project, and Lost Remote's Cory Bergman looked at TBD and other local TV online branding efforts.

— Advertising Age's Ann Marie Kerwin has an illuminating list of 10 trends in global media consumption.

— Finally, two good pieces from the Lab: Harvard prof Nicholas Christakis on why popularity doesn't equal influence on social media, and The New York Times' Aron Pilhofer and Jennifer Preston provided a glimpse into how one very influential news organization is evolving on social media.

Similar posts: Cephalexin No Rx. Buy Retin A No Prescription. Order Diflucan. Armour results. Synthroid price, coupon. Armour price, coupon.
Trackbacks from: Purchase Zoloft. Purchase Zoloft. Purchase Zoloft. Zoloft results. Zoloft pics. Buy Zoloft from mexico.